Optibrium appoints Dr Tim Hohm as Director of Commercial Strategy and Business Development
February 18, 2020
Tim Hohm to further develop Optibrium’s sales and business strategy for global market expansion CAMBRIDGE, UK – Optibrium™, a developer of software for drug discovery, today announced the appointment of Dr Tim Hohm as Director of Commercial Strategy and Business Development. Tim will be responsible for leading the Company’s commercial strategy and sales processes, with a [...]
February 18, 2020
Important Note: the methods and solutions described in this press release are for research use only and not for use in clinical diagnostic procedures Faellanden, Switzerland: Bruker today announces the release of the B.I.QUANT-UR™ 1.1 module, the only analysis solution on the market that complies with DIN-ISO criteria for the identification and quantification of urine metabolites on [...]
KKR Forms Life Sciences Tools Platform Gamma Biosciences
February 18, 2020
New Platform to Support Innovation in Bioprocessing for Advanced Biologic Therapies KKR, a leading global investment firm, today announced the formation of a new platform, Gamma Biosciences ("Gamma" or "the Company"), which will operate a portfolio of companies focused on next-generation bioprocessing technologies for the production of advanced biologic therapies. KKR and co-investors have committed [...]
February 18, 2020
LIVERMORE, Calif.-- S2 Genomics, a manufacturer and provider of automated tissue sample preparation systems, and the RIKEN Center for Integrative Medical Sciences (IMS), a leading genomics research institute, today announced that RIKEN IMS has joined the S2 Genomics Early Technology Access Program to evaluate and further develop single cell sequencing applications on the S2 Genomics [...]
February 18, 2020
THOROLD, ON - Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acid and protein stabilization and purification, today announced that they are offering a number of products to the scientific and medical community to support the study of the 2019 Novel Coronavirus (COVID-19, formerly 2019-nCoV) [...]
Covaris launches novel viral RNA extraction kits for swab sample collection devices
February 18, 2020
– Covaris announced new kits for efficient viral RNA extraction from sterile, synthetic swabs – Covaris is supporting customers evaluating kits as a key component in the development of accurate COVID-19 virus detection assays WOBURN, Mass. — Covaris, Inc. today announced the release of two new kits for viral RNA extraction from nasal or throat [...]
Covaris launches novel viral RNA extraction kits for swab sample collection devices
February 18, 2020
– Covaris announced new kits for efficient viral RNA extraction from sterile, synthetic swabs – Covaris is supporting customers evaluating kits as a key component in the development of accurate COVID-19 virus detection assays WOBURN, Mass.— Covaris, Inc. today announced the release of two new kits for viral RNA extraction from nasal or throat swab [...]
Shoreline Biome launches new DNA isolation product
February 18, 2020
Kit isolates high molecular weight single-stranded DNA efficiently, without bias FARMINGTON, Conn.— Shoreline Biome, a microbiome research company that develops tools for characterizing microbiome populations down to the strain level, recently unveiled a novel DNA isolation product. Shoreline Rapid Prep is a fast and easy-to-use kit designed for efficient and unbiased isolation of high molecular weight [...]
SGI-DNA Equipping Researchers With Critical Tools to Combat Coronavirus Disease (COVID-2019)
February 18, 2020
Synthetic biology company taking major steps in worldwide effort to put a stop to the SARS-CoV-2 (formerly known as 2019-nCoV) outbreak, including co-funding purchases of BioXp™ 3200 System. SGI-DNA is enabling researchers to quickly print DNA required to discover vaccines and therapeutics. SGI-DNA, creators of the BioXp™ 3200 System and Gibson Assembly® Reagents, announces a focused [...]
Euformatics and bio.logis launch collaboration to provide PGx results for NGS diagnostics
February 17, 2020
HELSINKI, Finland – Euformatics partners with bio.logis to enable laboratories using its tertiary analysis platform to provide patients with pharmacogenomic dosing recommendations. While being the topic of countless talks at conferences about personalized medicine for more than a decade, there are encouraging signs, indicating that pharmacogenomic testing is finally finding its way into clinical care. [...]
